#moderna

[ follow ]
#norovirus

Vaccine for winter vomiting bug to be trialled on thousands

A new norovirus vaccine trial aims to protect vulnerable populations and reduce healthcare system burdens during winter months.

Doctors trial world's first vaccine against vomiting bug norovirus

A groundbreaking clinical trial is underway for the world's first norovirus vaccine, aimed at reducing health and economic tolls linked to the virus.

Vaccine for winter vomiting bug to be trialled on thousands

A new norovirus vaccine trial aims to protect vulnerable populations and reduce healthcare system burdens during winter months.

Doctors trial world's first vaccine against vomiting bug norovirus

A groundbreaking clinical trial is underway for the world's first norovirus vaccine, aimed at reducing health and economic tolls linked to the virus.
morenorovirus
#mrna-vaccine

Two-in-one flu and Covid jab passes advanced trial

Moderna's combined flu and Covid vaccine shows promising results in phase-three trials, offering convenience with one shot for both diseases.

US prepares for bird flu pandemic with $176M Moderna vaccine deal

The US government will pay Moderna $176 million to develop an mRNA vaccine for pandemic influenza amid the spread of H5N1 in US dairy cattle.

As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccine

The US government is considering funding late-stage trials for Moderna's mRNA pandemic bird flu vaccine to bolster its pandemic jab stockpile.

Northwestern University Sues Moderna Over Spikevax Vaccine

Northwestern University alleges Moderna infringed on patents related to mRNA vaccine delivery technology developed at the university, prompting a lawsuit.

Two-in-one flu and Covid jab passes advanced trial

Moderna's combined flu and Covid vaccine shows promising results in phase-three trials, offering convenience with one shot for both diseases.

US prepares for bird flu pandemic with $176M Moderna vaccine deal

The US government will pay Moderna $176 million to develop an mRNA vaccine for pandemic influenza amid the spread of H5N1 in US dairy cattle.

As bird flu spreads in cows, US close to funding Moderna's mRNA H5 vaccine

The US government is considering funding late-stage trials for Moderna's mRNA pandemic bird flu vaccine to bolster its pandemic jab stockpile.

Northwestern University Sues Moderna Over Spikevax Vaccine

Northwestern University alleges Moderna infringed on patents related to mRNA vaccine delivery technology developed at the university, prompting a lawsuit.
moremrna-vaccine
#stock-market

Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans

Moderna is reducing its R&D budget by 20%, impacting future vaccine development due to low sales projections.
The company faces challenges following its pandemic success, prompting a strategic shift in investment.

Cambridge-based Moderna lays out plan to slice research and development spending

Moderna expects to break even by 2028, delaying its previous 2026 target due to revenue forecast disappointments.

Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans

Moderna is reducing its R&D budget by 20%, impacting future vaccine development due to low sales projections.
The company faces challenges following its pandemic success, prompting a strategic shift in investment.

Cambridge-based Moderna lays out plan to slice research and development spending

Moderna expects to break even by 2028, delaying its previous 2026 target due to revenue forecast disappointments.
morestock-market
#covid-19

What to know about Moderna's combined covid-flu vaccine on the horizon

Moderna's combined coronavirus-influenza vaccine triggers higher immune response in older adults, expected to improve coverage and accessibility by fall 2025.

Summer COVID Wave Prompts Early Emergency Approval of New Vaccines

The FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.

A Combined Flu and COVID-19 Shot May Be Coming

Moderna's combination COVID-19/influenza shot showed better immune responses than separate vaccines.

Medicine is going personalised': Moderna's UK boss on the coming vaccine revolution

Pfizer's former UK vaccine leader is now overseeing the construction of Moderna's manufacturing and research center in Oxfordshire.
The Moderna site is dedicated to the production of mRNA vaccines against new Covid variants and other illnesses.

What to know about Moderna's combined covid-flu vaccine on the horizon

Moderna's combined coronavirus-influenza vaccine triggers higher immune response in older adults, expected to improve coverage and accessibility by fall 2025.

Summer COVID Wave Prompts Early Emergency Approval of New Vaccines

The FDA has approved updated vaccines from Pfizer and Moderna to combat the KP.2 COVID-19 strain amid severe summer infections.

A Combined Flu and COVID-19 Shot May Be Coming

Moderna's combination COVID-19/influenza shot showed better immune responses than separate vaccines.

Medicine is going personalised': Moderna's UK boss on the coming vaccine revolution

Pfizer's former UK vaccine leader is now overseeing the construction of Moderna's manufacturing and research center in Oxfordshire.
The Moderna site is dedicated to the production of mRNA vaccines against new Covid variants and other illnesses.
morecovid-19

Moderna secures a second FDA vaccine approval as Spikevax sales plummet

Moderna's mRESVIA vaccine approved by FDA for adults 60 and older, showing high efficacy against RSV.
#mrna-technology

An mRNA Melanoma Vaccine Shows Promise

Moderna's mRNA technology shows promise in treating melanoma with positive results in a phase 2 study.

U.S. government will give Moderna $176 million to develop bird flu vaccine

The U.S. government is funding Moderna to develop a pandemic vaccine for bird flu, leveraging mRNA technology used in COVID-19 vaccines.

US Pays Moderna $176 Million to Develop Bird Flu Vaccine Amid Waves of Outbreaks

Moderna will use mRNA technology to develop a vaccine for the H5N1 virus, similar to the COVID-19 vaccine development.

A Combination COVID and Flu Vaccine Is Coming Soon

A single vaccine from Moderna can protect against SARS-CoV-2 and influenza more effectively than separate vaccines.
Moderna's mRNA-based vaccine for both SARS-CoV-2 and influenza is proven more effective in adults over 50 years old.
Combination vaccines utilizing mRNA technology show promise for public health despite challenges in development costs and time.

Moderna's mRNA dreams meet reality with first post-Covid shot

The upcoming RSV shot by Moderna showcases the potential of mRNA technology to treat various illnesses beyond Covid.

US pays Moderna millions to develop bird flu jab

Developing mRNA-based pandemic influenza vaccine to combat bird flu with US government funding.

An mRNA Melanoma Vaccine Shows Promise

Moderna's mRNA technology shows promise in treating melanoma with positive results in a phase 2 study.

U.S. government will give Moderna $176 million to develop bird flu vaccine

The U.S. government is funding Moderna to develop a pandemic vaccine for bird flu, leveraging mRNA technology used in COVID-19 vaccines.

US Pays Moderna $176 Million to Develop Bird Flu Vaccine Amid Waves of Outbreaks

Moderna will use mRNA technology to develop a vaccine for the H5N1 virus, similar to the COVID-19 vaccine development.

A Combination COVID and Flu Vaccine Is Coming Soon

A single vaccine from Moderna can protect against SARS-CoV-2 and influenza more effectively than separate vaccines.
Moderna's mRNA-based vaccine for both SARS-CoV-2 and influenza is proven more effective in adults over 50 years old.
Combination vaccines utilizing mRNA technology show promise for public health despite challenges in development costs and time.

Moderna's mRNA dreams meet reality with first post-Covid shot

The upcoming RSV shot by Moderna showcases the potential of mRNA technology to treat various illnesses beyond Covid.

US pays Moderna millions to develop bird flu jab

Developing mRNA-based pandemic influenza vaccine to combat bird flu with US government funding.
moremrna-technology

I thought I had Covid - it was another, unbearably painful, disease'

HIV patient contracts monkeypox, describes the painful experience.
Encouraging participation in mpox vaccine trials for potential life-changing impact.

Here's why Pfizer, Moderna COVID vaccines do not affect DNA, experts say

Florida Surgeon General Joseph Ladapo is facing criticism from federal regulators for spreading unfounded safety concerns about Pfizer and Moderna's COVID-19 vaccines.
Ladapo claims that the vaccines could potentially affect people's DNA and raise concerns about a possible cancer risk, but the FDA and vaccine experts have dismissed his claims.

Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs

Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma.

Moderna soars on analyst upgrade | Entrepreneur

Moderna saw a 13% stock surge after an analyst upgraded the stock and predicted five product approvals by 2026.
Despite a challenging 2023, Moderna's future growth relies on its diverse pipeline of new products.

Merck-Moderna vaccine cuts odds of skin cancer recurrence in half, study finds

A vaccine developed by Moderna and Merck shows promising results in treating the most deadly form of skin cancer.
Those who received the vaccine and Merck's cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years.
#pandemic-influenza

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

The U.S. government is funding Moderna to expedite pandemic influenza vaccine development, adaptable to different strains of influenza.

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

The US government is paying Moderna $176 million to develop an mRNA vaccine against pandemic influenza amidst the spread of H5N1 in US dairy cattle.

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

The U.S. government is funding Moderna to expedite pandemic influenza vaccine development, adaptable to different strains of influenza.

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

The US government is paying Moderna $176 million to develop an mRNA vaccine against pandemic influenza amidst the spread of H5N1 in US dairy cattle.
morepandemic-influenza
#vaccine-development

Moderna receives $176 million to accelerate development of pandemic bird flu vaccine as concerns grow

Moderna receiving $176 million for pandemic flu vaccine development following bird flu outbreak.

Combined COVID-flu vaccines are coming: Moderna jab clears major test

A single vaccine from Moderna protects against both SARS-CoV-2 and influenza more effectively than individual vaccines.

Moderna receives $176 million to accelerate development of pandemic bird flu vaccine as concerns grow

Moderna receiving $176 million for pandemic flu vaccine development following bird flu outbreak.

Combined COVID-flu vaccines are coming: Moderna jab clears major test

A single vaccine from Moderna protects against both SARS-CoV-2 and influenza more effectively than individual vaccines.
morevaccine-development

Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial

Moderna's combo flu and COVID vaccine generates a strong immune response in older adults, potentially offering a promising solution in combating respiratory illnesses.
[ Load more ]